Scholars Central

Conference abstractPublished 7 Sep 2017

Adverse events in patients with Multidrug-Resistant Tuberculosis: Results of a prospective cohort study at tertiary care level

Authors: Gaurav Gupta

All Institute of Medical Sciences, New Delhi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND: Drug resistance Tuberculosis (DR-TB) is a public health crisis and its diagnosis and management is challenging task. One of the major obstacles in achieving successful treatment outcomes in DR-TB are adverse events affecting the adherence to the second line drugs (SLD). OBJECTIVE: To evaluate the frequency of adverse events due to the second line drugs in Multidrug-Resistant Tuberculosis (MDR-TB) patients. METHODS: A prospective cohort study was conducted at DOTS Plus site at AIIMS, New Delhi .The cohort of 81 MDR-TB were recruited between June 2014 to June 2016 and were provided with standardized RNCTP regimen. Patients were followed up and adverse events were primarily recognized with clinical evidence and/or laboratory investigations. Data was collected in pre-designed proforma. The data was analyzed by stata 14 and presented in mean (standard deviation)/median (min to max) and frequency (%) with confidence interval (95%). RESULTS: 91 adverse events were reported in 52(64.1%) patients. Only 1.2 %( 1/81) of the patient stopped treatment, but 9.8% (8/81) required removal of the suspected drug(s) from the regimen due to adverse events. The grouped adverse events were most commonly gastrointestinal (70.6%), arthralgia (10.9%), ototoxicity (6.4%), psychiatric (5.5%), and hypothyroidism (2.1%).Eight (9.8%) patients had major adverse events requiring discontinuation or substitution of drugs that included psychiatric disturbances in 5(6.1%) followed by hearing loss and tinnitus in 3(3.7%). CONCLUSIONS: In India Programmatic management of drug resistance tuberculosis (PMDT) guidelines provides excellent guidance for diagnosis and treatment of DR-TB. Adverse events can be catered if addressed at the time by the health care system and adherence can be assured for successful treatment outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectInfectious Diseases
  • SubjectPulmonology & Respiratory
  • BylineArticles whose byline prints “Gaurav Gupta”